TrialPharmacology research & perspectives2017

Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study.

Jutta Beier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.